Jianjun Gao

Jianjun Gao is a Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on genitourinary cancers, particularly bladder cancer and renal cell carcinoma, with an emphasis on cancer immunotherapy and immune checkpoint inhibitors. His recent work includes multimodal spatial omics modeling (MISO, MorphLink) and clinical trials combining sitravatinib with nivolumab plus ipilimumab in advanced clear cell renal cell carcinoma. His 2025 publications span Nature Methods and Nature Communications, integrating tissue complexity resolution with translational oncology. He also explores HER2 in urothelial carcinoma and debulking surgery in metastatic disease.